Ra Capital Management, L.P. Alector, Inc. Transaction History

Ra Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$14.84 - $22.23 $24 Million - $35.9 Million	-1,616,879 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$9.4 - $16.7 $18.8 Million - $33.4 Million	-2,001,869 Reduced 55.32%	1,616,879 $24.5 Million
Q3 2020 Nov 16, 2020	SELL	$10.54 - $24.96 $5.36 Million - $12.7 Million	-508,600 Reduced 12.32%	3,618,748 $38.1 Million
Q1 2020 May 15, 2020	BUY	$16.25 - $35.28 $50.8 Million - $110 Million	3,127,348 Added 312.73%	4,127,348 $99.6 Million
Q1 2019 May 15, 2019	BUY	$15.97 - $22.5 $16 Million - $22.5 Million	1,000,000 New	1,000,000 $18.7 Million

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.